Educational services, namely, seminars, blogs, websites and other materials in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations).

Medical and pharmaceutical research and development services; scientific and technological research services related thereto; clinical trials.